Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II
Journal of Medical Virology · 2023-03 · 95 (3)
DOI: 10.1002/jmv.28643 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 15.03.2023. Verfasst von Elena Criscuolo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy. Hauptthemen laut MEDLINE: Mpox, Monkeypox, Smallpox, Smallpox Vaccine. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Since early May 2022, some monkeypox virus (MPXV) infections have been reported from countries where the disease is not endemic. Within 2 months, the number of patients has increased extensively, becoming the most considerable MPXV outbreak described. Smallpox vaccines demonstrated high efficacy against MPXVs in the past and are considered a crucial outbreak control measure. However, viruses isolated during the current outbreak carry distinct genetic variations, and the cross‐neutralizing capability of antibodies remains to be assessed. Here we report that serum antibodies elicited by first‐generation smallpox vaccines can neutralize the current MPXV more than 40 years after vaccine administration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Microbiology and Virology, Vita-Salute San Raffaele University, Milan, Italy.
- SCVSA Department, University of Parma, Parma, Italy.
- IRCCS San Raffaele Hospital, Milan, Italy.
- Synlab Italia, Castenedolo (BS), Italy.
ORCID-Profile: Elena Criscuolo, Benedetta Giuliani, Roberto Ferrarese, Davide Ferrari, Nicasio Mancini, Nicola Clementi
Zitieren
APA
Criscuolo, E., Giuliani, B., Ferrarese, R., Ferrari, D., Locatelli, M., Clementi, M., Mancini, N., & Clementi, N. (2023). Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II. Journal of Medical Virology, 95(3). https://doi.org/10.1002/jmv.28643
Vancouver
Criscuolo E, Giuliani B, Ferrarese R, Ferrari D, Locatelli M, Clementi M, et al. Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II. Journal of Medical Virology. 2023;95(3). doi:10.1002/jmv.28643
BibTeX
@article{Criscuolo2023,
author = {Criscuolo, Elena and Giuliani, Benedetta and Ferrarese, Roberto and Ferrari, Davide and Locatelli, Massimo and Clementi, Massimo and Mancini, Nicasio and Clementi, Nicola},
title = {Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {3},
doi = {10.1002/jmv.28643}
}
EUVIMED